Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/01/2013 | 01:27pm CEST
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TEVA PHARMACEUTICAL INDUST
08/20 TEVA PHARMACEUTICAL INDUSTRIES : US Congress to investigate Copaxone price hikes
08/20 TEVA PHARMACEUTICAL INDUSTRIES : launches generic testosterone boost treatment
08/18DJCorrection to Biogen Treads Tricky Path Between Politicians, Investors Articl..
08/18 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Axiron® i..
08/17 Drugmaker Hikma trims sales forecasts, shares fall
08/17 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Today's Research Reports on Stocks to Wat..
08/15 TEVA PHARMACEUTICAL INDUSTRIES : Check Point overtakes Teva to become Israel's m..
08/11 TEVA PHARMACEUTICAL INDUSTRIES : parties as share price plunges to new low
08/10 TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of Generic Epiduo® in the Unit..
08/10 TEVA PHARMACEUTICAL INDUSTRIES : Ayalim Mutual Funds buying Teva shares
More news
News from SeekingAlpha
08/18 Teva Pharmaceutical Industries Limited 2017 Q2 - Results - Earnings Call Slid..
08/18 Teva launches generic Axiron in U.S.
08/18 SNIPPET ROUNDUP : Transparency For Straumann But A Black Box For Pfizer
08/18 TGIF - Market Ends Week On A Rough Note
08/18 Tracking John Paulson's Paulson & Company Portfolio - Q2 2017 Update
Financials ($)
Sales 2017 23 033 M
EBIT 2017 6 610 M
Net income 2017 -
Debt 2017 31 255 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 2,13x
EV / Sales 2018 2,01x
Capitalization 17 816 M
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 31,3 $
Spread / Average Target 78%
EPS Revisions
Managers
NameTitle
Yitzhak Peterburg President & Chief Executive Officer
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael R. Hayden President-Global Research & Development
Roger Abravanel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-54.03%17 816
JOHNSON & JOHNSON15.12%355 979
NOVARTIS7.69%216 915
ROCHE HOLDING LTD.3.78%216 699
PFIZER0.59%194 554
MERCK AND COMPANY4.45%167 705